Cibus Inc
NASDAQ:CBUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cibus Inc
NASDAQ:CBUS
|
US |
|
T
|
Test Research Inc
TWSE:3030
|
TW |
|
I
|
Ionis Pharmaceuticals Inc
XMUN:ISI
|
US |
|
F
|
Figeac Aero SARL
SWB:1F1
|
FR |
|
Y
|
Yara International ASA
DUS:IU2
|
NO |
|
C
|
C29 Metals Ltd
ASX:C29
|
AU |
|
M
|
Myriad Genetics Inc
LSE:0K3W
|
US |
|
N
|
Neo Cremar Co Ltd
KOSDAQ:311390
|
KR |
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
IN |
|
N
|
NXP Semiconductors NV
F:VNX
|
NL |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CBUS's stock price target?
Not Available
CBUS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Cibus Inc?
Projected CAGR
94%
Over the last 9 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 94%.